Current established protocols for the in vitro expansion of T cells face several problems like induction of apoptosis by stimulation of the T cell receptor complex (TCR), expansion of only subpopulations of CD4+ T cells or unwanted release of pro-inflammatory cytokines. The present method for expansion of T cells in vitro leads to a remarkable expansion of those T cells in complete absence of anti-CD3 antibodies and superagonistic anti-CD28 monoclonal antibodies. Hereby, the engagement of TCR is avoided and an unbiased expansion of T cell, in particular CD4+ T cell, subsets is achieved. The unbiased expansion of CD4+ T cells is reflected by maintained responsiveness of the expanded CD4+ T cells towards polyclonal stimuli and antigenic recall antigens in comparison to non-expanded CD4+ T cells.
Further information: PDF
Bayerische Patentallianz GmbH
Phone: +49 89 5480177-0
As Germany's association of technology- and patenttransfer agencies TechnologieAllianz e.V. is offering businesses access to the entire range of innovative research results of almost all German universities and numerous non-university research institutions. More than 2000 technology offers of 14 branches are beeing made accessable to businesses in order to assure your advance on the market. At www.technologieallianz.de a free, fast and non-bureaucratic access to all further offers of the German research landscape is offered to our members aiming to sucessfully transfer technologies.
firstname.lastname@example.org | TechnologieAllianz e.V.
Quat primer polymers the universal key to permanent surface functionalization
27.02.2017 | TechnologieAllianz e.V.
Novel carbonization process of PAN-nanofiber mats with enhanced surface area and porosity
20.02.2017 | TechnologieAllianz e.V.
13.02.2017 | Event News
10.02.2017 | Event News
09.02.2017 | Event News
28.02.2017 | Physics and Astronomy
28.02.2017 | Materials Sciences
28.02.2017 | Health and Medicine